Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
There has been a lot of media “chatter” over the past 3 days about an article published in the journal Cancer Research. The article suggests that an investigational genetic test can project the presence of prostate cancer in biopsy-based specimens with an average accuracy of 97 percent.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, gene, genetics, profiling, risk | Leave a Comment »
One of the problems with the PSA test is that it identifies a possible risk for prostate cancer in many men each year who are subsequently shown — by prostate biopsy — to be at no risk for the actual clinical condition.
Filed under: Diagnosis, Risk | Tagged: biopsy, Diagnosis, gene, profiling, risk | Leave a Comment »
There was a report on the AP news service yesterday which suggested that, “Scientists have taken a first step toward improving those problematic PSA tests for prostate cancer, by mixing in some genetic information that might help tell which men really need a biopsy.”
Filed under: Diagnosis, Risk | Tagged: genetics, profiling, PSA, risk | Leave a Comment »
There’s an article in today’s Wall Street Journal that begins, “Scientists may soon be able to answer the agonizing question facing men with prostate cancer.” The agonizing question is whether a specific individual actually needs early and aggressive treatment for his cancer or can simply monitor it for risk of progression.
Filed under: Diagnosis, Management, Risk | Tagged: classification, genetics, profiling, progression, risk | 3 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site